DaVinci robot: “A Pseudo-Innovation — Increases Costs Without Improving Patients’ Health” | Audet & Partners, LLP

DaVinci robot: “a pseudo-innovation — increases costs without improving patients’ health”

Recently, MedPageToday reported on a paper presented at the American Urological Association annual meeting:

“Robotic-assisted radical prostatectomy (RARP) cost 60% more than an open procedure, a difference driven primarily by higher operating-room costs, according to data from one large medical center.

On average, robotic procedures cost $6,000 more than open procedures, and the hospital lost approximately $4,000 on each robotic procedure.

The robotic technique accounted for 60% of the total cost of each RARP, Jeffrey Tomaszewski, MD, reported here at the American Urological Association meeting.

Read more: http://www.healthnewsreview.org/2012/05/davinci-robot-a-pseudo-innovation-increases-costs-without-improving-patients-health/

Join a class action. Call us: 800.965.1461